Matthew Davids, MD, MMSc

Director, Clinical Research, Division of Lymphoma Physician

Matthew Davids, MD, MMSc

Dr. Davids completed his M.D. cum laude at Yale University School of Medicine. He served as an intern, resident, and assistant chief resident in internal medicine at New York-Presbyterian Weill Cornell Medical Center and Memorial Sloan-Kettering Cancer Center in New York City. He then completed his fellowship in hematology and oncology in Dana-Farber/Partners CancerCare, and a Masters in Medical Science (M.M.S.c.) at Harvard Medical School.

View full profile

Related Videos

Matthew Davids, MD, MMSc discusses time-limited AVO triplet therapy Video

Matthew Davids, MD, MMSc discusses time-limited AVO triplet therapy

In a new study published in the Journal of Clinical Oncology and presented at #ASH24, Matthew Davids, MD, MMSC, of Dana-Farber Cancer Institute, shared promising findings: a time-limited AVO triplet therapy offers durable remission for high-risk CLL patients.

Blood Cancer Research: Clinical Trial Helps Younger Patient Video

Blood Cancer Research: Clinical Trial Helps Younger Patient

A patient shares her journey getting diagnosed with chronic lymphocytic leukemia in her 30's. Dana-Farber Cancer Institute's Matthew Davids, MD, MMSc, enrolled her on a clinical trial and details the results of that study. The research ...

Blood Cancer Research: Clinical trial helps younger patient Video

Blood Cancer Research: Clinical trial helps younger patient

Dr. Matthew Davids presented a study that demonstrated the ibrutinib+FCR drug combination keeps chronic lymphocytic leukemia in young patients in remission for several years.